Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients

NCT02623946 is registered in ClinicalTrials.gov with Clinique Neuro-Outaouais as lead sponsor.

NCT NCT02623946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02623946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients
Lead sponsor
Clinique Neuro-Outaouais
Phase
Observational
Overall status
Completed
Start date
November 30, 2015
Completion date
February 28, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis